Shenzhen Lianjia Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Lianjia Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MERVNE. The owner is based in Shenzhen.

Gushu Community, Bao'an Dist.

Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MERVNE
MERVNE
Registered 2023

Trademark Classifications

Shenzhen Lianjia Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Lianjia Biotechnology Co., Ltd. have?

Shenzhen Lianjia Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Lianjia Biotechnology Co., Ltd. file in?

Shenzhen Lianjia Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Shenzhen Lianjia Biotechnology Co., Ltd.'s most well-known trademarks?

Shenzhen Lianjia Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as MERVNE. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Lianjia Biotechnology Co., Ltd.'s trademark registration success rate?

Shenzhen Lianjia Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.